Health Trials

Early or Locally Advanced HER2-positive Breast Cancer

1

Review clinical trials related to Early or Locally Advanced HER2-positive Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer

This randomized, controlled, open-label, multicenter study will evaluate the safety and efficacy of KN026 in combination with HB1801 ± Carboplatin as neoadjuvant therapy in patients with early or locally advanced HER2-positive breast cancer.

Participants needed: 520
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai JMT-Bio Inc.Updated: Apr 24, 2025Locations: 1
Eligibility criteria

Voluntarily participate in the experiment and sign the informed consent; [+7]

Inflammatory or bilateral breast cancer; [+7]

Read more